Cas no 81446-29-9 ((-)-pinoresinol)
(-)-pinoresinol Chemical and Physical Properties
Names and Identifiers
-
- (-)-pinoresinol
- (+)-
- (+-)-1c,4c-Bis-(4-hydroxy-3-methoxy-phenyl)-(3ar,6ac)-tetrahydro-furo[3,4-c]furan
- (+)-Pinoresinol
- (+/-)-pinoresinol
- (7S,7'S,8R,8'R)-3,3'-dimethoxy-7,9':7',9-diepoxylignane-4,4'-diol
- 1,4-Bis-(4-hydroxy-3-methoxy-phenyl)-tetrahydro-furo[3,4-c]furan
- 2,2'-dimethoxy-4,4'-(tetrahydro-furo[3,4-c]furan-1,4-diyl)-bis-phenol
- 2,6-bis-(3-methoxy-4-hydroxy phenyl)-cis-3,7-dioxabicyclo[3.3.0]octane
- 2,6-di(4-hydroxy-3-methoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane
- pinoresinol
- (+)-syringaresinol
- pinoresinol monomethyl ether
- 1H,3H-Furo[3,4-c]furan, phenol deriv. (ZCI)
- 4,4′-[(1R,3aS,4R,6aS)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxyphenol] (ACI)
- Phenol, 4,4′-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis[2-methoxy-, [1R-(1α,3aα,4α,6aα)]- (ZCI)
- Q27155117
- 41607-20-9
- (-)-pinoresinol glucoside
- CHEMBL573336
- C17529
- AKOS040762633
- FS-6845
- CHEBI:81162
- D85072
- Epipinoresinol-4-O-beta-D-glucoside
- (2S,3R,4S,5S,6R)-2-[4-[(3R,3aS,6R,6aS)-3-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
- HY-N0946
- CS-0016079
- (-)-Pinoresinol 4-O-glucoside
- Q27135716
- SCHEMBL15481159
- (7beta,7'beta,8beta,8'beta)-3,3'-dimethoxy-7,9':7',9-diepoxylignane-4,4'-diol
- GLXC-14834
- CHEMBL267963
- BDBM50208826
- C20455
- 4-[(3R,3aS,6R,6aS)-6-(3-methoxy-4-oxidanyl-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxy-phenol
- AKOS040760637
- 81446-29-9
- 4-[(3R,3aS,6R,6aS)-6-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenol
- FS-7642
- 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxyphenol
- 4,4'-(1R,3aS,4R,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diylbis(2-methoxyphenol)
- (?)-Pinoresinol
- CHEBI:67245
- 4,4'-(1R,3aS,4R,6aS)-tetrahydro-1H,3H-furo(3,4-c)furan-1,4-diylbis(2-methoxyphenol)
- DA-59411
- 4-((3R,3aS,6R,6aS)-6-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro(3,4-c)furan-3-yl)-2-methoxyphenol
-
- Inchi: 1S/C20H22O6/c1-23-17-7-11(3-5-15(17)21)19-13-9-26-20(14(13)10-25-19)12-4-6-16(22)18(8-12)24-2/h3-8,13-14,19-22H,9-10H2,1-2H3/t13-,14-,19+,20+/m1/s1
- InChI Key: HGXBRUKMWQGOIE-NSMLZSOPSA-N
- SMILES: O(C1C(O)=CC=C([C@@H]2OC[C@H]3[C@H](C4C=CC(O)=C(OC)C=4)OC[C@@H]23)C=1)C
Computed Properties
- Exact Mass: 358.14200
- Monoisotopic Mass: 520.19446183g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 26
- Rotatable Bond Count: 4
- Complexity: 741
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 9
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.5
- Topological Polar Surface Area: 157?2
Experimental Properties
- Color/Form: Powder
- Density: 1.287±0.06 g/cm3 (20 oC 760 Torr),
- Melting Point: 119-120 oC
- Boiling Point: 556.5±50.0 °C at 760 mmHg
- Flash Point: 290.4±30.1 °C
- Solubility: Very slightly soluble (0.14 g/l) (25 o C),
- PSA: 77.38000
- LogP: 3.19020
- Vapor Pressure: 0.0±1.6 mmHg at 25°C
(-)-pinoresinol Security Information
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:Store at 4 ℃, better at -4 ℃
(-)-pinoresinol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| ChemFaces | CFN92287-5mg |
(-)-Pinoresinol |
81446-29-9 | >=98% | 5mg |
$268 | 2021-07-22 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | P27990-5mg |
Pinoresinol |
81446-29-9 | 5mg |
¥2400.0 | 2021-09-08 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN2079-5 mg |
(-)-Pinoresinol |
81446-29-9 | 5mg |
¥2814.00 | 2022-04-26 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN2079-5mg |
(-)-Pinoresinol |
81446-29-9 | 99.78% | 5mg |
¥ 3980 | 2023-09-08 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN2079-10mg |
(-)-Pinoresinol |
81446-29-9 | 99.78% | 10mg |
¥ 5970 | 2023-09-08 | |
| TargetMol Chemicals | TN2079-5mg |
(-)-Pinoresinol |
81446-29-9 | 99.78% | 5mg |
¥ 2380 | 2024-07-20 | |
| TargetMol Chemicals | TN2079-10mg |
(-)-Pinoresinol |
81446-29-9 | 99.78% | 10mg |
¥ 3400 | 2024-07-20 | |
| ChemFaces | CFN92287-5mg |
(-)-Pinoresinol |
81446-29-9 | >=98% | 5mg |
$268 | 2023-09-19 | |
| TargetMol Chemicals | TN2079-5 mg |
(-)-Pinoresinol |
81446-29-9 | 99.78% | 5mg |
¥ 3,980 | 2023-07-11 | |
| A2B Chem LLC | AH49923-500mg |
(-)-Pinoresinol |
81446-29-9 | 98% by HPLC | 500mg |
$16969.00 | 2024-04-19 |
(-)-pinoresinol Production Method
Production Method 1
1.2 Reagents: Hydrochloric acid Solvents: Water ; acidified
Production Method 2
Production Method 3
2.1 Reagents: Glucose , Sucrose , Potassium chloride , Sulfuric acid magnesium salt (1:1) , Ferrous sulfate , Dipotassium phosphate Solvents: Dimethyl sulfoxide , Water ; 72 h, 25 °C
Production Method 4
Production Method 5
Production Method 6
2.1 Reagents: Oxygen Catalysts: Laccase Solvents: Ethanol , Water ; pH 5, rt; 1 h, rt
2.2 Reagents: Hydrochloric acid Solvents: Water ; acidified
Production Method 7
2.1 Reagents: Diisobutylaluminum hydride Solvents: Toluene ; 40 min, 0 °C; 1 h, 0 °C
3.1 Reagents: Oxygen Catalysts: Laccase Solvents: Ethanol , Water ; pH 5, rt; 1 h, rt
3.2 Reagents: Hydrochloric acid Solvents: Water ; acidified
Production Method 8
Production Method 9
Production Method 10
2.1 Reagents: Glucose , Sucrose , Potassium chloride , Sulfuric acid magnesium salt (1:1) , Ferrous sulfate , Dipotassium phosphate Solvents: Dimethyl sulfoxide , Water ; 72 h, 25 °C
(-)-pinoresinol Raw materials
- (E)-Ferulic acid
- (+)-de-4'-O-methyleudesmin
- (E)-Coniferol
- Coniferyl alcohol
- Eudesmin
- Pinoresinol
- (-)-Eudesmin
- 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, ethyl ester, (E)-
(-)-pinoresinol Preparation Products
(-)-pinoresinol Related Literature
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
-
Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
Additional information on (-)-pinoresinol
Recent Advances in the Study of (-)-Pinoresinol (CAS: 81446-29-9): A Comprehensive Research Brief
(-)-Pinoresinol, a lignan compound with the CAS number 81446-29-9, has garnered significant attention in the field of chemical biology and pharmaceutical research due to its diverse biological activities. Recent studies have explored its potential applications in anti-inflammatory, antioxidant, and anticancer therapies. This research brief synthesizes the latest findings on (-)-pinoresinol, focusing on its molecular mechanisms, therapeutic potential, and recent advancements in extraction and synthesis methodologies.
One of the most notable breakthroughs in (-)-pinoresinol research is its role in modulating inflammatory pathways. A 2023 study published in the *Journal of Natural Products* demonstrated that (-)-pinoresinol significantly inhibits the NF-κB signaling pathway, reducing the production of pro-inflammatory cytokines such as TNF-α and IL-6. This finding suggests its potential as a lead compound for developing novel anti-inflammatory drugs. Additionally, its antioxidant properties have been linked to the scavenging of reactive oxygen species (ROS), which are implicated in various chronic diseases.
In the realm of cancer research, (-)-pinoresinol has shown promise as an adjuvant therapy. A recent in vitro study revealed its ability to induce apoptosis in human breast cancer cells (MCF-7) by upregulating caspase-3 activity and downregulating Bcl-2 expression. These results, published in *Bioorganic & Medicinal Chemistry Letters*, highlight the compound's potential to enhance the efficacy of conventional chemotherapeutic agents while minimizing side effects.
Advances in the extraction and synthesis of (-)-pinoresinol have also been reported. A 2024 study in *Green Chemistry* introduced a sustainable enzymatic method for the stereoselective synthesis of (-)-pinoresinol, achieving a yield of 85% with minimal environmental impact. This method addresses the challenges associated with traditional chemical synthesis, such as low selectivity and high energy consumption, paving the way for scalable production.
Despite these promising developments, challenges remain in the clinical translation of (-)-pinoresinol. Pharmacokinetic studies indicate low oral bioavailability, necessitating the development of novel drug delivery systems. Recent efforts have explored nanoparticle-based formulations to enhance its solubility and stability, as reported in the *International Journal of Pharmaceutics*. These innovations could significantly improve the therapeutic potential of (-)-pinoresinol in clinical settings.
In conclusion, (-)-pinoresinol (CAS: 81446-29-9) represents a multifaceted compound with substantial therapeutic potential. Its anti-inflammatory, antioxidant, and anticancer properties, coupled with advancements in synthesis and delivery technologies, position it as a promising candidate for future drug development. Continued research is essential to overcome existing limitations and fully harness its benefits in biomedicine.
81446-29-9 ((-)-pinoresinol) Related Products
- 177313-81-4(3,4-Furandimethanol, a4,2-bis(3,4-dimethoxyphenyl)tetrahydro-,(a4R,2S,3S,4R)-)
- 160550-16-3(3,4-Furandimethanol, α4,2-bis(3,4-dimethoxyphenyl)tetrahydro- (9CI))
- 487-39-8(Phillygenin)
- 16499-02-8(Diaeudesmin)
- 23397-47-9(Phenol,4-[(1R,3aS,4S,6aS)-4-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxy-)
- 10061-38-8(Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI))
- 160472-98-0(3-Furanmethanol,2-(3,4-dimethoxyphenyl)-4-[(3,4-dimethoxyphenyl)methoxymethyl]tetrahydro- (9CI))
- 148057-46-9(Membrin)
- 29395-87-7(Phenol,4-[(1S,3aR,4S,6aR)-4-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxy-)
- 163564-91-8(3-Furanmethanol,4-[ethoxy(4-hydroxy-3-methoxyphenyl)methyl]tetrahydro-a-(4-hydroxy-3-methoxyphenyl)-(9CI))